AVDL

Avadel Pharmaceuticals
AVDL

Overview Fund Trends Analyst Outlook Journalist POV

59 hedge funds and large institutions have $51M invested in Avadel Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 19 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

63% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 19

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $76K

Holders
59
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$76K
Net Calls
Net Calls Change

Top Buyers

1
+$2.02M
2
+$826K
3
+$800K
4
Ameriprise
Ameriprise
Minnesota
+$468K
5
HCM
Highbridge Capital Management
New York
+$253K

Top Sellers

1
-$2.12M
2
-$1.98M
3
-$1.92M
4
PCM
Portolan Capital Management
Massachusetts
-$661K
5
CAM
Close Asset Management
United Kingdom
-$641K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$2K
52
$2K
53
$1K
54
$1K
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
1 2
3